How a private testing lab realigned its services to meet the needs of the global pandemicAvailable on-demand
Size exclusion native mass spectrometry for the characterization of monoclonal antibodiesAvailable on-demand
Population-wide immune responses to SARS-CoV-2: Insights from quantifying the antibody responseAvailable on-demand
Evaluating therapeutic antibodies: Quantification of ADCP using advanced flow cytometryAvailable on-demand
From B cells to yeast – diverse approaches to rapid discovery of COVID-19 therapeutic antibodiesAvailable on-demand
Rapid in-solution equilibrium approach to KD determination of biotherapeutic drug candidatesAvailable on-demand
A high-throughput test for neutralizing antibodies to SARS-CoV-2 as alternative to live virus neutralization and immunoglobulin detectionAvailable on-demand
Advanced characterization of protein isoforms using direct cIEF-MS, prep cIEF, LCMS, peptide mapping and other techniquesAvailable on-demand
High throughput antibody discovery targeting cell surface receptors for signaling blocking in cancerAvailable on-demand
Qualitative and quantitative characterization of antibodies and proteins by CE-MS, LC-MS and an automated immunoaffinity purification (IA)- CE-MS workflow in vitro and in vivoAvailable on-demand
From Boutique to global: Chimeric antigen receptor T-Cells as a model for clinical development and commercializationAvailable on-demand
Using direct CIEF-MS and prep-CIEF for MS-characterization of protein isoforms, LC-MS analysis, peptide mapping and other techniquesAvailable on-demand